Literature DB >> 22985642

Practice patterns of surveillance endoscopy in a Veterans Affairs database of 29,504 patients with Barrett's esophagus.

Hashem B El-Serag1, Zhigang Duan, Marilyn Hinojosa-Lindsey, Jason Hou, Mohammad Shakhatreh, Aanand D Naik, G John Chen, Richard L Street, Jennifer R Kramer.   

Abstract

BACKGROUND: Practice guidelines recommend surveillance endoscopy every 2 to 3 years among patients with Barrett's esophagus (BE) to detect early neoplastic lesions. Although surveys report that >95% of gastroenterologists recommend or practice BE surveillance, the extent and patterns of surveillance in clinical practice are unknown.
OBJECTIVE: To identify the extent and determinants of endoscopic surveillance among BE patients.
DESIGN: Retrospective cohort study.
SETTING: A total of 121 Veterans Affairs facilities nationwide. PATIENTS: Veteran patients with BE diagnosed from 2003 to 2009, with follow-up through September 30, 2010. INTERVENTION: Not an interventional study. MAIN OUTCOME MEASUREMENTS: The proportions of patients with BE who received any EGD after the index BE EGD date. In the subgroup of patients with at least 6 years of follow-up, we also calculated proportions for regular (EGD during both 3-year intervals), irregular (EGD in only 1 interval), and no surveillance. We examined differences in demographics and clinical and facility factors among these groups in unadjusted and adjusted analyses.
RESULTS: We identified 29,504 patients with BE; 97% were men, 83% white, and their mean age was 61.8 years. During a 3.8-year median follow-up period, 45.4% of patients with BE received at least one EGD. Among the subgroup of 4499 patients with BE who had at least 6 years of follow-up, 23.0% had regular surveillance, and 26.7% had irregular surveillance. There was considerable facility-level variation in percentages with surveillance EGD across the 112 facilities and by geographic region of these facilities. Demographic and clinical factors did not explain these variations. Patients with at least one EGD were significantly more likely to be white; to be aged <65 years, with a low level of comorbidity; to have GERD, obesity, dysphagia, or esophageal strictures; to have more outpatient visits; and to be seen in smaller hospitals (<87 beds) than those without any EGD. LIMITATIONS: There might be misclassification of BE and surveillance EGD. Lack of pathology data on dysplasia, which dictates surveillance intervals.
CONCLUSION: Endoscopic surveillance for BE is considerably less commonly practiced in Veterans Affairs facilities than is self-reported by physicians. Although several clinical factors are associated with variations in surveillance, facility-level factors play a large role. The comparative effectiveness of the different practice-based surveillance patterns needs to be examined.
Copyright © 2012 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22985642      PMCID: PMC4689298          DOI: 10.1016/j.gie.2012.06.022

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  18 in total

1.  Management of Barrett's esophagus: a national study of practice patterns and their cost implications.

Authors:  C P Gross; M I Canto; J Hixson; N R Powe
Journal:  Am J Gastroenterol       Date:  1999-12       Impact factor: 10.864

2.  Surveillance of Barrett's oesophagus: physicians' practices and review of current guidelines.

Authors:  J W van Sandick; J F Bartelsman; J J van Lanschot; G N Tytgat; H Obertop
Journal:  Eur J Gastroenterol Hepatol       Date:  2000-01       Impact factor: 2.566

3.  Prevalence of Barrett's esophagus in the general population: an endoscopic study.

Authors:  Jukka Ronkainen; Pertti Aro; Tom Storskrubb; Sven-Erik Johansson; Tore Lind; Elisabeth Bolling-Sternevald; Michael Vieth; Manfred Stolte; Nicholas J Talley; Lars Agréus
Journal:  Gastroenterology       Date:  2005-12       Impact factor: 22.682

4.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

Authors:  R A Deyo; D C Cherkin; M A Ciol
Journal:  J Clin Epidemiol       Date:  1992-06       Impact factor: 6.437

5.  The frequency of Barrett's esophagus in high-risk patients with chronic GERD.

Authors:  Brenda Westhoff; Scott Brotze; Allan Weston; Christian McElhinney; Rachel Cherian; Matthew S Mayo; Holly J Smith; Prateek Sharma
Journal:  Gastrointest Endosc       Date:  2005-02       Impact factor: 9.427

6.  The burden of upper gastrointestinal endoscopy in patients with Barrett's esophagus.

Authors:  M E Kruijshaar; M Kerkhof; P D Siersema; E W Steyerberg; M Y V Homs; M-L Essink-Bot
Journal:  Endoscopy       Date:  2006-09       Impact factor: 10.093

7.  Improving surveillance for Barrett's oesophagus.

Authors:  Peter A Bampton; Anne Schloithe; Jeff Bull; Robert J Fraser; Rob T A Padbury; David I Watson
Journal:  BMJ       Date:  2006-06-03

8.  Current practice in surveillance strategy for patients with Barrett's oesophagus in the UK.

Authors:  A Mandal; R J Playford; A C Wicks
Journal:  Aliment Pharmacol Ther       Date:  2003-05-15       Impact factor: 8.171

9.  Barrett's oesophagus: an audit of surveillance over a 17-year period.

Authors:  Lisa Gladman; Warren Chapman; Tariq H Iqbal; Joan C Gearty; Brian T Cooper
Journal:  Eur J Gastroenterol Hepatol       Date:  2006-03       Impact factor: 2.566

10.  Features of gastroesophageal reflux disease in women.

Authors:  Mona Lin; Lauren B Gerson; Runa Lascar; Marta Davila; George Triadafilopoulos
Journal:  Am J Gastroenterol       Date:  2004-08       Impact factor: 10.864

View more
  8 in total

Review 1.  Race/Ethnicity and overuse of care: a systematic review.

Authors:  Nancy R Kressin; Peter W Groeneveld
Journal:  Milbank Q       Date:  2015-03       Impact factor: 4.911

2.  An Accurate Cancer Incidence in Barrett's Esophagus: A Best Estimate Using Published Data and Modeling.

Authors:  Sonja Kroep; Iris Lansdorp-Vogelaar; Joel H Rubenstein; Harry J de Koning; Reinier Meester; John M Inadomi; Marjolein van Ballegooijen
Journal:  Gastroenterology       Date:  2015-04-29       Impact factor: 22.682

3.  Patient experiences with surveillance endoscopy: a qualitative study.

Authors:  Jennifer Arney; Marilyn Hinojosa-Lindsey; Richard L Street; Jason Hou; Hashem B El-Serag; Aanand D Naik
Journal:  Dig Dis Sci       Date:  2014-02-06       Impact factor: 3.199

4.  Use of Appropriate Surveillance for Patients With Nondysplastic Barrett's Esophagus.

Authors:  Anna Tavakkoli; Henry D Appelman; David G Beer; Chaitra Madiyal; Maryam Khodadost; Kimberly Nofz; Val Metko; Grace Elta; Thomas Wang; Joel H Rubenstein
Journal:  Clin Gastroenterol Hepatol       Date:  2018-02-09       Impact factor: 11.382

5.  Facility-Level Variations in Kidney Disease Care among Veterans with Diabetes and CKD.

Authors:  Sankar D Navaneethan; Julia M Akeroyd; David Ramsey; Sarah T Ahmed; Shiva Raj Mishra; Laura A Petersen; Paul Muntner; Christie Ballantyne; Wolfgang C Winkelmayer; Venkat Ramanathan; Salim S Virani
Journal:  Clin J Am Soc Nephrol       Date:  2018-11-29       Impact factor: 8.237

Review 6.  Patients' intuitive judgments about surveillance endoscopy in Barrett's esophagus: a review and application to models of decision-making.

Authors:  M Hinojosa-Lindsey; J Arney; S Heberlig; J R Kramer; R L Street; H B El-Serag; A D Naik
Journal:  Dis Esophagus       Date:  2013-02-05       Impact factor: 3.429

7.  Decision aids for shared decision-making in Barrett's esophagus surveillance.

Authors:  Aanand D Naik; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2014-05-10       Impact factor: 11.382

8.  Clinical and psychosocial variables associated with behavioral intentions to undergo surveillance endoscopy.

Authors:  John M Hollier; Marilyn Hinojosa-Lindsey; Shubhada Sansgiry; Hashem B El-Serag; Aanand D Naik
Journal:  BMC Gastroenterol       Date:  2014-06-10       Impact factor: 3.067

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.